MGNet: Exploring Factors Leading to Relapse After B Cell Depletion Therapy in Patients with Myasthenia Gravis

Dec 5, 2022 · 2m 11s
MGNet: Exploring Factors Leading to Relapse After B Cell Depletion Therapy in Patients with Myasthenia Gravis
Description

New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Acta Neuropathologica Communications on October 28, 2022, titled "Reemergence...

show more
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Acta Neuropathologica Communications on October 28, 2022, titled "Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy."

Read the paper here: https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-022-01454-0

Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
show less
Information
Author RDCRN
Organization RDCRN
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search